Inhaled corticosteroids and risk of upper respiratory tract infection in patients with asthma: a meta-analysis

[1]  H. Inoue,et al.  Epidemiology of asthma-chronic obstructive pulmonary disease overlap (ACO). , 2018, Allergology international : official journal of the Japanese Society of Allergology.

[2]  K. Samitas,et al.  An algorithmic approach for the treatment of severe uncontrolled asthma , 2018, ERJ Open Research.

[3]  Yuejun Du,et al.  Long-term use of inhaled corticosteroids and risk of upper respiratory tract infection in chronic obstructive pulmonary disease: a meta-analysis , 2017, Inhalation toxicology.

[4]  C. Wainwright,et al.  Inhaled Corticosteroids and Respiratory Infections in Children With Asthma: A Meta-analysis , 2017, Pediatrics.

[5]  Haoyan Wang,et al.  Efficacy and safety evaluation of once-daily fluticasone furoate/vilanterol in Asian patients with asthma uncontrolled on a low- to mid-strength inhaled corticosteroid or low-dose inhaled corticosteroid/long-acting beta2-agonist. , 2016, Allergy and asthma proceedings.

[6]  Margaret M. Johnson,et al.  Inhaled corticosteroids and incident pneumonia in patients with asthma: Systematic review and meta-analysis. , 2015, Acta medica academica.

[7]  A. Woodcock,et al.  Fluticasone furoate-vilanterol 100-25 mcg compared with fluticasone furoate 100 mcg in asthma: a randomized trial. , 2014, The journal of allergy and clinical immunology. In practice.

[8]  A. Woodcock,et al.  Once-daily fluticasone furoate 50 mcg in mild-to-moderate asthma: a 24-week placebo-controlled randomized trial , 2014, Allergy.

[9]  A. Woodcock,et al.  Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial , 2014, Respiratory Research.

[10]  A. Woodcock,et al.  Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: a 24-week placebo and active-controlled randomised trial. , 2014, Respiratory medicine.

[11]  N. Thomson,et al.  Inhaled corticosteroids for asthma: on-demand or continuous use , 2013, Expert review of respiratory medicine.

[12]  J. Lötvall,et al.  Modulation of allergen-induced bronchoconstriction by fluticasone furoate and vilanterol alone or in combination , 2013, Allergy.

[13]  A. von Groll,et al.  Inhaled corticosteroids increase the risk of oropharyngeal colonization by Streptococcus pneumoniae in children with asthma , 2012, Respirology.

[14]  Michael Noonan,et al.  Efficacy and Safety of Budesonide and Formoterol in One Pressurised Metered-Dose Inhaler in Adults and Adolescents with Moderate to Severe Asthma , 2012, Drugs.

[15]  A. Woodcock,et al.  Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma , 2011, Respiratory research.

[16]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[17]  A. Woodcock,et al.  Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial , 2011, Respiratory research.

[18]  A. Woodcock,et al.  Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial , 2011, Thorax.

[19]  C. Bias.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials , 2011 .

[20]  S. Suissa,et al.  Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada. , 2009, Arthritis and rheumatism.

[21]  Yoon K Loke,et al.  Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. , 2009, Archives of internal medicine.

[22]  Sonal Singh,et al.  Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. , 2009, Archives of internal medicine.

[23]  A. Chuchalin,et al.  Salmeterol/Fluticasone Propionate via Diskus™ Once Daily versus Fluticasone Propionate Twice Daily in Patients with Mild Asthma not Previously Receiving Maintenance Corticosteroids , 2008, Clinical drug investigation.

[24]  B. Make,et al.  Inhaled corticosteroids in chronic obstructive pulmonary disease. , 2007, Proceedings of the American Thoracic Society.

[25]  P. Korenblat,et al.  Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma. , 2007, Clinical therapeutics.

[26]  E. Kerwin,et al.  Inhaled mometasone furoate reduces oral prednisone usage and improves lung function in severe persistent asthma. , 2007, Respiratory Medicine.

[27]  Bartolome Celli,et al.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.

[28]  P. Dorinsky,et al.  Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study. , 2006, Clinical therapeutics.

[29]  C. Crim,et al.  Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroids. , 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[30]  W. Busse,et al.  Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids , 2005, Current medical research and opinion.

[31]  P. Patel,et al.  Maintenance of asthma control by once‐daily inhaled ciclesonide in adults with persistent asthma , 2005, Allergy.

[32]  A. Sheffer,et al.  Long-term safety of once-daily budesonide in patients with early-onset mild persistent asthma: results of the Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START) study. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[33]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[34]  P. Barnes,et al.  Efficacy and Safety of Inhaled Corticosteroids in Asthma , 1993 .

[35]  P. Barnes,et al.  Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992. , 1993, The American review of respiratory disease.

[36]  E. Juniper,et al.  Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. , 1990, The American review of respiratory disease.